Abstract
Serotonin (5-hydroxytryptamine; 5-HT) is a potent constrictor of isolated blood vessels. However, recent studies demonstrate that chronic 5-HT infusion results in a prolonged fall in blood pressure in the rat. This finding highlights the need for further study of 5-HT in the cardiovascular system. We tested the hypothesis that a functional serotonin transporter (SERT) is critical to enabling a 5-HT-induced fall in blood pressure. Experiments were performed in male and female rats to determine whether gender significantly affected the ability of 5-HT to lower blood pressure and to determine whether SERT dependence was different in male vs. female rats. 5-HT (25 μg/kg/min; s.c.) was infused for 7 days to male and female, SERT wild-type (WT) and SERT knockout (KO) rats. Mean arterial pressure (MAP) and heart rate were monitored via radiotelemetry. 5-HT produced a significantly greater fall in MAP (at the nadir) in the male SERT WT rat (−20 ± 1 mmHg) compared to the male SERT KO rat (−10 ± 2 mmHg). Similarly, 5-HT also produced a significantly greater fall in MAP (at the nadir) in the female SERT WT rat (−19 ± 1 mmHg) compared to the female SERT KO rat (−15 ± 0.4 mmHg). While the lack of a functional SERT protein did not prevent a 5-HT-induced fall in blood pressure, it did reduce the ability of 5-HT to lower blood pressure in the male and female SERT rat, suggesting a potentially important role for SERT in producing a 5-HT-induced fall in blood pressure.
References
Brenner B, Harney JT, Ahmed BA, Jeffus BC, Unal R, Mehta JL, Kilic F (2007) Plasma serotonin levels and the platelet serotonin transporter. J Neurochem 102:206–215
Chanrion B, Mannoury la Cour C, Bertaso F, Lerner-Natoli M, Freissmuth M, Millan MJ, Brockaert J, Martin P (2007) Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity. PNAS 104:8119–8124
Dahlstroem A, Fuxe K (1964) Evidence for the existence of monamine-containing neurons in the central nervous system. I. Demonstration of monamines in the cell bodies of brain stem neurons. Acta Physiol Scand 232(Suppl):1–55
Diaz J, Ni W, Thompson J, King A, Fink G, Watts SW (2008) 5-hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats. J Pharmacol Exp Ther 325:1031–1038
Erspamer V, Aerso B (1952) Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine. Nature 169:800–801
Fetkovska N, Pletscher A, Ferracin F, Amstein R, Buhler FR (1990) Impaired uptake of 5-hydroxytryptamine in platelet in essential hypertension: clinical relevance. Cardiovasc Drugs Ther 4:105–109
Homberg JR, Olivier JDA, Smits BMG, Mul JD, Mudde J, Verheul NOFM, Cools AR, Ronken E, Cremers T, Schoffelmeer ANM, Ellenbroek BA, Cuppen E (2007) Characterization of the serotonin transporter knockout rat: a selective change in the functioning of the serotonergic system. Neuroscience 146:1662–1676
Linder AE, Diaz J, Ni W, Szasz T, Burnett R, Watts SW (2008a) Vascular reactivity, 5-HT uptake, and blood pressure in the serotonin transporter knockout rat. Am J Physiol Heart Circ Physiol 294:H1745–H1752
Linder AE, Ni W, Szasz T, Burnett R, Diaz J, Geddes TJ, Kuhn DM, Watts SW (2008b) A serotonergic system in veins: serotonin transporter-independent uptake. J Pharmacol Exp Ther 325:714–722
Maron E, Toru I, Hirvonen J et al. (2011) Gender differences in brain serotonin transporter availability in panic disorder. J Psychopharmacol (in press)
Nakatani Y, Sato-Suzuki I, Tsujino N, Nakasato A, Seki Y, Fumoto M (2008) Augmented brain 5-HT crosses the blood–brain barrier through the 5-HT transporter in rat. Eur J Neurosci 27:2466–2472
Ni W, Thompson JM, Northcott CA, Lookingland K, Watts SW (2004) The serotonin transporter is present and functional in peripheral arterial smooth muscle. J Cardiovasc Pharmacol 43:770–781
Rapport MM, Green AA, Page IH (1948) Serum vasoconstrictor (serotonin): IV isolation and characterization. J Biol Chem 176:1243–1251
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Patrick Davis, R., Linder, A.E. & Watts, S.W. Lack of the serotonin transporter (SERT) reduces the ability of 5-hydroxytryptamine to lower blood pressure. Naunyn-Schmiedeberg's Arch Pharmacol 383, 543–546 (2011). https://doi.org/10.1007/s00210-011-0622-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-011-0622-1